Nephrol Dial Transplant (2002) 17: 21-23
© 2002 European Renal Association-European Dialysis and Transplant Association
SECTION II: Haemodialysis adequacy
II.2 Haemodialysis dose quantification: middle molecules (MM)
AbstractGuideline II.2.1
A. ß2-m is representative in its kinetic behaviour of other MM and peptides of similar size, and may be used as a marker for such molecules.
(Evidence level: B)
Guideline II.2.2
A. To enhance MM removal, synthetic high-flux membranes should be used. Additional strategies, such as adding a convective component, or increasing HD time or frequency, should be used to maximize MM removal.
(Evidence level: B)